An official website of the United States government
Home
Name
7+3
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
6/12/23 Moved to hidden status
Drugs for 7+3
Name
Alternate Names
CL 232315
Mitoxantrone Hydrochloride
Mitozantrone
Novantrone
Abbreviations
DAD
DHAD
DHAQ
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
301739
Primary Site
Histology
None
Remarks
Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione
Coding
This drug should be coded
Name
Alternate Names
Acetyladriamycin
Cerubidine
Dauno-blastin
Daunomycin
Daunomycin-HCl
Daunorubicin
Daunorubicine
FI-6339
Leuk-aemomycin C
NDC-0082-4155
RP-13057
Rubidomycin
Rubidomycin HCl
Rubomycin C
Abbreviations
Daun
Dauno
DNM
DNR
DRB
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
082151
82151
Primary Site
Leukemia
Histology
None
Remarks
FDA approved use on ALL and ANLL; antitumor antibiotic
Coding
This drug should be coded
Name
Alternate Names
4-Demethoxydaunorubicin
Idamycin
Idamycin PFS
Idarubicin hydrochloride
IMI 30
IMI-30
SC-33428
Abbreviations
4-DMDR
IDA
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
256439
Primary Site
Chronic myelogenous leukemia in blast crises
Myelodysplastic syndromes (MDS)
Histology
None
Remarks
An anthracycline antineoplastic agent. FDA approved uses on acute lymphocytic and non-lymphcytic leukemia.
Coding
This drug should be coded
Name
Alternate Names
AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453
Abbreviations
ara-C
CA
HDA
HDARA-C
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
063878
63878
Primary Site
Histology
None
Remarks
Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)
Coding
This drug should be coded
